BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 8844812)

  • 1. Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesis.
    Kadlubar F; Kaderlik RK; Mulder GJ; Lin D; Butler MA; Teitel CH; Minchin RF; Ilett KF; Friesen MD; Bartsch H
    Princess Takamatsu Symp; 1995; 23():207-13. PubMed ID: 8844812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
    Badawi AF; Stern SJ; Lang NP; Kadlubar FF
    Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetyltransferase-dependent activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine: formation of 2-amino-1-methyl-6-(5-hydroxy)phenylimidazo [4,5-b]pyridine, a possible biomarker for the reactive dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Frandsen H; Alexander J
    Carcinogenesis; 2000 Jun; 21(6):1197-203. PubMed ID: 10837010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of glucuronidation on the bioactivation and DNA adduction of the cooked-food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in vivo.
    Malfatti MA; Ubick EA; Felton JS
    Carcinogenesis; 2005 Nov; 26(11):2019-28. PubMed ID: 15944213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The urinary metabolite profile of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine is predictive of colon DNA adducts after a low-dose exposure in humans.
    Malfatti MA; Dingley KH; Nowell-Kadlubar S; Ubick EA; Mulakken N; Nelson D; Lang NP; Felton JS; Turteltaub KW
    Cancer Res; 2006 Nov; 66(21):10541-7. PubMed ID: 17079477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-specific human N-acetyltransferase 2 (NAT2) expression in the mouse.
    Leff MA; Epstein PN; Doll MA; Fretland AJ; Devanaboyina US; Rustan TD; Hein DW
    J Pharmacol Exp Ther; 1999 Jul; 290(1):182-7. PubMed ID: 10381774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The capability of rat colon tissue slices to metabolize the cooked-food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Malfatti MA; Connors MS; Mauthe RJ; Felton JS
    Cancer Res; 1996 Jun; 56(11):2550-5. PubMed ID: 8653696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine-induced DNA adducts and genotoxicity in chinese hamster ovary (CHO) cells expressing human CYP1A2 and rapid or slow acetylator N-acetyltransferase 2.
    Metry KJ; Zhao S; Neale JR; Doll MA; States JC; McGregor WG; Pierce WM; Hein DW
    Mol Carcinog; 2007 Jul; 46(7):553-63. PubMed ID: 17295238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder.
    Badawi AF; Hirvonen A; Bell DA; Lang NP; Kadlubar FF
    Cancer Res; 1995 Nov; 55(22):5230-7. PubMed ID: 7585581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice.
    Lin DX; Lang NP; Kadlubar FF
    Drug Metab Dispos; 1995 Apr; 23(4):518-24. PubMed ID: 7600922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1.
    Nelson CP; Kidd LC; Sauvageot J; Isaacs WB; De Marzo AM; Groopman JD; Nelson WG; Kensler TW
    Cancer Res; 2001 Jan; 61(1):103-9. PubMed ID: 11196146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of unmetabolized and phase II conjugates of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans: relationship to cytochrome P4501A2 and N-acetyltransferase activity.
    Stillwell WG; Kidd LC; Wishnok JS; Tannenbaum SR; Sinha R
    Cancer Res; 1997 Aug; 57(16):3457-64. PubMed ID: 9270013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine induces a higher number of aberrant crypt foci in Fischer 344 (rapid) than in Wistar Kyoto (slow) acetylator inbred rats.
    Purewal M; Velasco M; Fretland AJ; Hein DW; Wargovich MJ
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):529-32. PubMed ID: 10815700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of DNA adduct formation of PhIP in female F344 rats by dietary conjugated linoleic acid.
    Josyula S; He YH; Ruch RJ; Schut HA
    Nutr Cancer; 1998; 32(3):132-8. PubMed ID: 10050262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rat extrahepatic tissues.
    Kaderlik KR; Minchin RF; Mulder GJ; Ilett KF; Daugaard-Jenson M; Teitel CH; Kadlubar FF
    Carcinogenesis; 1994 Aug; 15(8):1703-9. PubMed ID: 8055652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an ATP-dependent pathway of activation for the heterocyclic amine carcinogen N-hydroxy-2-amino-3-methylimidazo[4, 5-f]quinoline.
    Agus C; Ilett KF; Kadlubar FF; Minchin RF
    Carcinogenesis; 2000 Jun; 21(6):1213-9. PubMed ID: 10837012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro bioactivation of N-hydroxy-2-amino-alpha-carboline.
    King RS; Teitel CH; Kadlubar FF
    Carcinogenesis; 2000 Jul; 21(7):1347-54. PubMed ID: 10874013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer.
    Zhu J; Chang P; Bondy ML; Sahin AA; Singletary SE; Takahashi S; Shirai T; Li D
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):830-7. PubMed ID: 14504191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of N-acetyltransferase 2 polymorphism on tumor target tissue DNA adduct levels in rapid and slow acetylator congenic rats administered 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine or 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline.
    Metry KJ; Neale JR; Bendaly J; Smith NB; Pierce WM; Hein DW
    Drug Metab Dispos; 2009 Nov; 37(11):2123-6. PubMed ID: 19666988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP1A2 and NAT2 genotype/phenotype relations and urinary excretion of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in a human dietary intervention study.
    Moonen HJ; Moonen EJ; Maas L; Dallinga JW; Kleinjans JC; de Kok TM
    Food Chem Toxicol; 2004 Jun; 42(6):869-78. PubMed ID: 15110095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.